Concepedia

No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta

Julius Hollnberger, Yang Liu, Simin Xu, Silvia Chang, Ross Martin, Savrina Manhas, Thomas Aeschbacher, Bin Han, Tahmineh Yazdi, Lindsey May,

Journal of Hepatology · 2023 · 23 citations · 22 references

DOI

Concepts

References

22

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

Huan Yan, Guocai Zhong, Guangwei Xu et al. · eLife · 2012 · 2.1K citations · Full text

, , +13

Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes

Yi Ni, Florian A. Lempp, Stefan Mehrle et al. · Gastroenterology · 2013 · 766 citations · Full text

, , +11

Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen

Mark Yen‐Ping Kuo, Mei Chao, John M. Taylor · Journal of Virology · 1989 · 451 citations · Full text

, , +15

Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta

Benjamin Heidrich, Cihan Yurdaydın, Gökhan Kabaçam et al. · Hepatology · 2014 · 292 citations · Full text

, , +17

Molecular Determinants of Hepatitis B and D Virus Entry Restriction in Mouse Sodium Taurocholate Cotransporting Polypeptide

Huan Yan, Wenhui He, Guocai Zhong et al. · Journal of Virology · 2013 · 199 citations · Full text

, , +17